Updates
OCI Releases Complete DSCSA Interoperability Specification for 2023 Compliance
OCI’s complete DSCSA Interoperability Specification for 2023 Compliance is a set of specifications, conformance criteria, and resources is the culmination of a two-year effort to support the secured enhanced verification and tracing activities required by the U.S. Drug Supply Chain Security Act (DSCSA).
OCI-Hosted Virtual Conference “DSCSA for Dispensers and their Trading Partners” Charts the Course for Enhanced Drug Distribution Security
OCI in partnership with the NCPA ran a virtual conference on the DSCSA requirements geared towards dispensers and their trading partners. Participants included representatives from FDA, GS1, and PDG. While the full recording series is available on YouTube, here are some quick highlights from each day’s closing panel.
OCI SUPPORTS PDG TRACING EFFORT
OCI strongly supports and encourages the work undertaken by PDG in developing, advancing, and sustaining the effective and efficient model for interoperable tracing and verification of prescription pharmaceuticals as required by the DSCSA.
XATP, Spherity, Trust.med, and Legisym Announce Interoperable Effort to Secure DSCSA Verification, Tracing, and Recalls
XATP, Spherity, Trust.med, and Legisym announced interoperability between their digital wallet, credentialing, and routing services in support of secured enhanced verification and tracing activities required by the U.S. Drug Supply Chain Security Act (DSCSA).
OCI article published in Pharmaceutical Commerce, June issue
Closing a Key Gap in DSCSA Compliance - An article about the origin, purpose and our work at OCI.
XATP and Spherity Announce Interoperability for DSCSA Credentialing
XATP and Spherity announced interoperability between their digital wallet services in support of regulatory compliance with the U.S. Drug Supply Chain Security Act (DSCSA) by fall 2023. This key milestone enables trading partners using either platform to securely exchange and verify each other’s credentials as Authorized Trading Partners (ATPs).
OCI Closes U.S. DSCSA Compliance Gap with an Industry-First
OCI invites pharmaceutical supply chain actors into its Early Adopter Program to trial the industry’s first compliance solution for U.S. DSCSA Authorized Trading Partner authentication. The launch of the program now makes the industry’s first functional, scalable solution widely available enabling U.S. supply chain actors to become DSCSA-compliant well ahead of the deadline.
Open Credentialing Initiative (OCI) Gains Momentum Supporting DSCSA Compliance for Authorized Trading Partners
OCI, a collaborative industry effort, issued a call for the pharmaceutical industry to align on core standards around Authorized Trading Partner (ATP) authentication in compliance with the Drug Supply Chain Security Act (DSCSA). Formed by a group of trading partners, solution providers, and standards organizations, OCI is charting the course for ATP interoperability by 2023.